Stay updated on Immunotherapy in Stage IV Melanoma Patients Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page.

Latest updates to the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1; no visible changes to study details, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision: v3.3.1 added and v3.2.0 removed, and the main study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedThe government funding status notice/banner at the top of the page has been removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedTwo screenshots show the same study details page with no core-content changes; only metadata such as update dates appears different.SummaryDifference0.4%

- Check63 days agoChange DetectedThe page now states potential funding-related delays and current NIH Clinical Center operating status, and updates the version to v3.2.0, replacing v3.1.0.SummaryDifference3%

- Check70 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy in Stage IV Melanoma Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page.